J Stroke.
2019 Sep;21(3):241-241. 10.5853/jos.2019.02474.
Tackling Nonatrial Fibrillation Diseases Using Nonvitamin K Antagonist Oral Anticoagulant: by What and for Whom?
- Affiliations
-
- 1Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. jongskim@amc.seoul.kr
- KMID: 2464642
- DOI: http://doi.org/10.5853/jos.2019.02474
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A Recurrent Ischemic Stroke Stabilization after Using Non-Vitamin K Antagonist Oral Anticoagulant (NOAC)
- Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non‑vitamin K antagonist oral anticoagulants
- Antithrombotic Strategy in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention
- Use of NOAC in Cardioversion
- Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
